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Macrophages play a central role in innate immunity, contributing
to both the initiation and resolution of inﬂammation. Their
activation by interferon γ and lipopolysaccharide results in
increased production of nitric oxide (NO), stabilization of HIF-1α,
loss of mitochondrial function, and a switch to glycolytic metabo-
lism. We have now characterized these changes and their
bioenergetic consequences in J774.A1 macrophages. Following
activation, there was a stabilization of HIF-1α and a progressive
increase in extracellular NO which became detectable after 3 h. The
increase in NO was associated with a decrease in mitochondrial-
and an increase in non-mitochondrial O2 consumption. Mitochon-
drial ATP synthesis decreased while glycolytically-generated ATP
increased, more than compensating for the lack of mitochondrial
ATP synthesis. Despite this substantial increase in total ATP
generation, the steady state cellular ATP content fell due to the
increase in ATP demand by the cells, leading to an arrest in cell
proliferation and death. The mitochondrial defect in activated
macrophages could be prevented by treatment with the NO
synthase inhibitor SEITU, which also reduced the stabilization of
HIF-1α, partially suppressed glycolysis and restored the cellular ATP.
Conversely, knockdown of HIF-1α with siRNA reduced glycolysis
and NO production, partially preserved mitochondrial respiration
and restored the cellular ATP content. Activation of glycolysis was
completely abolished by knockdown of HIF-1α together with SEITU.
Thus our results indicate that NO and HIF-1α operate synergistically
to activate glycolysis during inﬂammation.
doi:10.1016/j.bbabio.2008.05.175
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In clinical practice Reamberin is used as an antihypoxant–
antioxidant–detoxicating solution. It is an isotonic solution which
contains sodium succinate 1.5%, sodium chloride 0.6%, potassium
chloride 0.03%, magnesium chloride 0.012% and is given by
intravenous administration. The aim of the study was to determine
functional activity of mitochondria from the intestines muscular
layer in acute peritonitis and to assess the inﬂuence of Reamberin
on their activity. The experiment was performed on 55 rabbits.
Peritonitis was induced by intraabdominal injection of polymicro-
bial suspension of E. coli and B. fragilis. Reamberin was injected
intravenously for 5 days starting 1 h after operation, at a dose of
25 mg/kg (succinate concentration). Mitochondrial oxygen con-
sumption was determined using polarographic method. Succinate
was used as a substrate. We demonstrated a signiﬁcant decrease in
mitochondrial function after 6 h of acute peritonitis. ADP/O ratio
was signiﬁcantly (pb0,05) reduced by 20±1(5)%. State III and IV
respiration were lowered for 49±3(5)% and 14±3(5)% respectively
(pb0,05), and the respiratory control ratio was reduced by 39±5
(5)% (pb0,05). These changes began on day one and waned by the
ﬁfth day of postoperative period. Our data show that Reamberinpreserves mitochondrial function during the ﬁrst 24 h after
operation and restores it to the ﬁfth day of the postoperative
period. Data are presented as mean±sd (n), where n is the number
of experiments.
doi:10.1016/j.bbabio.2008.05.176
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We analyzed apoptosis by PI (propinium iodide) staining and
FACS analysis in thymocytes treated with dexamethasone (0.1 µM),
for 2, 4 and 6 h [and controls treated with carrier alone] from wild-
type and UCP 1 knockout (KO) mice. We were able to show that
there was a ~15% decrease in amount of apoptosis in thymocytes
from knock-out mice compared to thymocytes from wild-type
animals after treatment with dexamethosone for 4 h (p=0.02) and
6 h (p=0.012). We also observed a ∼5% decrease in the amount of
(background) apoptosis in thymocytes from knock-out mice com-
pared to thymocytes from wild-type animals after treatment with
carrier for 6 h (p=0.005). We conclude that ablation of UCP 1 in
thymocytes effects susceptibility of thymocytes to apoptosis.
doi:10.1016/j.bbabio.2008.05.177
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Mitochondrial dysfunction has been associated with neurode-
generative disorders such as Parkinson's disease and Alzheimer's
disease, as post mortem studies have identiﬁed reduced electron
transport chain (ETC) activities in mitochondria from various brain
regions. In Parkinson's disease complex I is thought to be reduced
by up to 40% in certain brain regions and this ﬁnding has been used
as evidence for the theory that complex I defects are a cause of
neurodegeneration due to associated bioenergetic dysfunction. The
presence of heterogeneous mitochondria in the brain has compli-
cated matters as isolated nonsynaptic mitochondria have different
energy thresholds and ﬂux control coefﬁcients compared to isolated
mitochondria of synaptic origin. Complex I is known to exert a high
degree of control over oxidative phosphorylation in isolated
synaptic mitochondria, and it also contributes to low energy
thresholds such that when activities are reduced by 25% and
above, respiration rates and ATP levels are subsequently reduced. In
comparison to complex III and IV in nerve terminal mitochondria,
which possess lower ﬂux control coefﬁcients and energy thresholds
of 70 and 60%, respectively, complex I exerts a higher degree of
control on oxidative phosphorylation. Intact nerve terminals
(synaptosomes) possess even lower thresholds for complex I (15%),
that may have important implications for ATP levels and neuro-
transmitter release. The data suggest that defects in mitochondrial
complex I activities are of a higher signiﬁcance than other ETC
